nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallium nitrate—IL1B—Graves' disease	0.841	1	CbGaD
Gallium nitrate—Lung infiltration—Propylthiouracil—Graves' disease	0.00706	0.282	CcSEcCtD
Gallium nitrate—ATP6V1B2—eye—Graves' disease	0.00548	0.0858	CbGeAlD
Gallium nitrate—IL1B—Hematopoietic Stem Cell Differentiation—ABO—Graves' disease	0.00493	0.0705	CbGpPWpGaD
Gallium nitrate—BGLAP—connective tissue—Graves' disease	0.00452	0.0707	CbGeAlD
Gallium nitrate—ATP6V1B2—pituitary gland—Graves' disease	0.00407	0.0637	CbGeAlD
Gallium nitrate—ATP6V1B2—adipose tissue—Graves' disease	0.00405	0.0634	CbGeAlD
Gallium nitrate—IL1B—eye—Graves' disease	0.00401	0.0627	CbGeAlD
Gallium nitrate—IL1B—connective tissue—Graves' disease	0.00386	0.0604	CbGeAlD
Gallium nitrate—TF—eye—Graves' disease	0.00357	0.056	CbGeAlD
Gallium nitrate—ATP6V1B2—thyroid gland—Graves' disease	0.0035	0.0549	CbGeAlD
Gallium nitrate—BGLAP—adipose tissue—Graves' disease	0.00346	0.0542	CbGeAlD
Gallium nitrate—TF—connective tissue—Graves' disease	0.00344	0.0539	CbGeAlD
Gallium nitrate—BGLAP—thyroid gland—Graves' disease	0.003	0.0469	CbGeAlD
Gallium nitrate—IL1B—pituitary gland—Graves' disease	0.00297	0.0466	CbGeAlD
Gallium nitrate—IL1B—adipose tissue—Graves' disease	0.00296	0.0464	CbGeAlD
Gallium nitrate—TF—adipose tissue—Graves' disease	0.00264	0.0414	CbGeAlD
Gallium nitrate—RRM2—pituitary gland—Graves' disease	0.00262	0.041	CbGeAlD
Gallium nitrate—RRM2—adipose tissue—Graves' disease	0.00261	0.0409	CbGeAlD
Gallium nitrate—Renal failure acute—Propylthiouracil—Graves' disease	0.0026	0.104	CcSEcCtD
Gallium nitrate—IL1B—thyroid gland—Graves' disease	0.00256	0.0401	CbGeAlD
Gallium nitrate—TF—thyroid gland—Graves' disease	0.00229	0.0358	CbGeAlD
Gallium nitrate—RRM2—thyroid gland—Graves' disease	0.00226	0.0354	CbGeAlD
Gallium nitrate—IL1B—Type II interferon signaling (IFNG)—CXCL10—Graves' disease	0.00181	0.0259	CbGpPWpGaD
Gallium nitrate—IL1B—IL1 and megakaryotyces in obesity—ICAM1—Graves' disease	0.00169	0.0243	CbGpPWpGaD
Gallium nitrate—BGLAP—Interleukin-11 Signaling Pathway—ICAM1—Graves' disease	0.00167	0.0239	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—HLA-DRB1—Graves' disease	0.00161	0.023	CbGpPWpGaD
Gallium nitrate—Leukopenia—Methimazole—Graves' disease	0.00152	0.0608	CcSEcCtD
Gallium nitrate—IL1B—Type II interferon signaling (IFNG)—HLA-B—Graves' disease	0.00148	0.0211	CbGpPWpGaD
Gallium nitrate—Leukopenia—Propylthiouracil—Graves' disease	0.0013	0.0517	CcSEcCtD
Gallium nitrate—IL1B—IL1 and megakaryotyces in obesity—IFNG—Graves' disease	0.00129	0.0185	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Methimazole—Graves' disease	0.00125	0.0498	CcSEcCtD
Gallium nitrate—IL1B—IL27-mediated signaling events—IFNG—Graves' disease	0.00121	0.0173	CbGpPWpGaD
Gallium nitrate—IL1B—Type II interferon signaling (IFNG)—ICAM1—Graves' disease	0.0012	0.0172	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—IFNG—Graves' disease	0.00117	0.0168	CbGpPWpGaD
Gallium nitrate—BGLAP—Notch-mediated HES/HEY network—CD4—Graves' disease	0.00116	0.0167	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—CD4—Graves' disease	0.00113	0.0162	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—HLA-E—Graves' disease	0.00113	0.0162	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—CD40—Graves' disease	0.0011	0.0158	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Methimazole—Graves' disease	0.0011	0.0438	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—CTLA4—Graves' disease	0.00109	0.0156	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Propylthiouracil—Graves' disease	0.00106	0.0424	CcSEcCtD
Gallium nitrate—IL1B—IL12-mediated signaling events—CD8A—Graves' disease	0.00104	0.0149	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00104	0.0149	CbGpPWpGaD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—ICAM1—Graves' disease	0.00101	0.0145	CbGpPWpGaD
Gallium nitrate—Pruritus—Methimazole—Graves' disease	0.000983	0.0392	CcSEcCtD
Gallium nitrate—IL1B—IL12-mediated signaling events—FASLG—Graves' disease	0.000979	0.014	CbGpPWpGaD
Gallium nitrate—IL1B—IL12-mediated signaling events—IL2RA—Graves' disease	0.000939	0.0134	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Propylthiouracil—Graves' disease	0.000934	0.0373	CcSEcCtD
Gallium nitrate—IL1B—IL12-mediated signaling events—HLA-A—Graves' disease	0.000929	0.0133	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000927	0.0133	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—IFNG—Graves' disease	0.000912	0.0131	CbGpPWpGaD
Gallium nitrate—IL1B—Type II interferon signaling (IFNG)—IFNG—Graves' disease	0.000912	0.0131	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.000899	0.0129	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—HLA-DQB1—Graves' disease	0.000895	0.0128	CbGpPWpGaD
Gallium nitrate—IL1B—Cellular roles of Anthrax toxin—TNF—Graves' disease	0.000895	0.0128	CbGpPWpGaD
Gallium nitrate—Vomiting—Methimazole—Graves' disease	0.000883	0.0353	CcSEcCtD
Gallium nitrate—IL1B—IL23-mediated signaling events—CD4—Graves' disease	0.000881	0.0126	CbGpPWpGaD
Gallium nitrate—Rash—Methimazole—Graves' disease	0.000876	0.035	CcSEcCtD
Gallium nitrate—Dermatitis—Methimazole—Graves' disease	0.000875	0.0349	CcSEcCtD
Gallium nitrate—IL1B—IL12-mediated signaling events—HLA-DRB1—Graves' disease	0.000848	0.0121	CbGpPWpGaD
Gallium nitrate—Pruritus—Propylthiouracil—Graves' disease	0.000836	0.0334	CcSEcCtD
Gallium nitrate—Nausea—Methimazole—Graves' disease	0.000825	0.0329	CcSEcCtD
Gallium nitrate—IL1B—IFN-gamma pathway—IFNG—Graves' disease	0.000809	0.0116	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—HLA-B—Graves' disease	0.000804	0.0115	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.000804	0.0115	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—FASLG—Graves' disease	0.000786	0.0113	CbGpPWpGaD
Gallium nitrate—IL1B—IL27-mediated signaling events—TNF—Graves' disease	0.000783	0.0112	CbGpPWpGaD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—IFNG—Graves' disease	0.000772	0.0111	CbGpPWpGaD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000766	0.011	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—TNF—Graves' disease	0.00076	0.0109	CbGpPWpGaD
Gallium nitrate—IL1B—Alzheimers Disease—FAS—Graves' disease	0.000758	0.0109	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—FAS—Graves' disease	0.000758	0.0109	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—ICAM1—Graves' disease	0.000754	0.0108	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—IL2RA—Graves' disease	0.000754	0.0108	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—CD8A—Graves' disease	0.000753	0.0108	CbGpPWpGaD
Gallium nitrate—Vomiting—Propylthiouracil—Graves' disease	0.000751	0.03	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—HLA-A—Graves' disease	0.000745	0.0107	CbGpPWpGaD
Gallium nitrate—Rash—Propylthiouracil—Graves' disease	0.000745	0.0297	CcSEcCtD
Gallium nitrate—Dermatitis—Propylthiouracil—Graves' disease	0.000744	0.0297	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—CXCL10—Graves' disease	0.000715	0.0102	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000706	0.0101	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.000702	0.0101	CbGpPWpGaD
Gallium nitrate—Nausea—Propylthiouracil—Graves' disease	0.000702	0.028	CcSEcCtD
Gallium nitrate—IL1B—TCR Signaling Pathway—FAS—Graves' disease	0.000683	0.00978	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—HLA-DRB1—Graves' disease	0.000681	0.00975	CbGpPWpGaD
Gallium nitrate—IL1B—Monoamine Transport—TNF—Graves' disease	0.000663	0.00949	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.000627	0.00898	CbGpPWpGaD
Gallium nitrate—IL1B—IL12-mediated signaling events—IFNG—Graves' disease	0.00062	0.00887	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000599	0.00858	CbGpPWpGaD
Gallium nitrate—IL1B—IL12-mediated signaling events—CD4—Graves' disease	0.000598	0.00857	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—TNF—Graves' disease	0.00059	0.00845	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—IL2RA—Graves' disease	0.000587	0.0084	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—IFNG—Graves' disease	0.000574	0.00822	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000571	0.00817	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—IFNG—Graves' disease	0.000497	0.00712	CbGpPWpGaD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000496	0.0071	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—B3GNT2—Graves' disease	0.000475	0.0068	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—ICAM1—Graves' disease	0.000474	0.00679	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—TNF—Graves' disease	0.000457	0.00654	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—IFNG—Graves' disease	0.000456	0.00653	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—CD4—Graves' disease	0.000433	0.00619	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—FASLG—Graves' disease	0.00043	0.00615	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000427	0.00611	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—FAS—Graves' disease	0.000414	0.00593	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-E—Graves' disease	0.00041	0.00587	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IFNG—Graves' disease	0.000396	0.00567	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—TNF—Graves' disease	0.000372	0.00532	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—IFNG—Graves' disease	0.000361	0.00516	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000332	0.00475	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.000325	0.00466	CbGpPWpGaD
Gallium nitrate—IL1B—Alzheimers Disease—TNF—Graves' disease	0.000322	0.00461	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—TNF—Graves' disease	0.000322	0.00461	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—TNF—Graves' disease	0.000295	0.00423	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.000292	0.00418	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TSHR—Graves' disease	0.000276	0.00395	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.000274	0.00392	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.000271	0.00388	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000262	0.00376	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000247	0.00354	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000241	0.00345	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000237	0.0034	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—TNF—Graves' disease	0.000233	0.00334	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GC—Graves' disease	0.000227	0.00325	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—IL2RA—Graves' disease	0.00022	0.00315	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000205	0.00293	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—HLA-A—Graves' disease	0.000192	0.00275	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000187	0.00267	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000181	0.00259	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CXCL10—Graves' disease	0.000178	0.00255	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TNF—Graves' disease	0.000176	0.00252	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—B3GNT2—Graves' disease	0.000172	0.00246	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IFIH1—Graves' disease	0.00017	0.00244	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IL2RA—Graves' disease	0.000136	0.00195	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HLA-E—Graves' disease	0.000134	0.00192	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD40—Graves' disease	0.000131	0.00187	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CTLA4—Graves' disease	0.000129	0.00185	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CD4—Graves' disease	0.000124	0.00177	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HLA-DQB1—Graves' disease	0.000106	0.00152	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD8A—Graves' disease	9.92e-05	0.00142	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HLA-B—Graves' disease	9.54e-05	0.00137	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IL2RA—Graves' disease	8.94e-05	0.00128	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HLA-A—Graves' disease	8.84e-05	0.00127	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HLA-DRB1—Graves' disease	8.08e-05	0.00116	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—ICAM1—Graves' disease	7.75e-05	0.00111	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IFNG—Graves' disease	5.9e-05	0.000845	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD4—Graves' disease	5.7e-05	0.000816	CbGpPWpGaD
